Bank of America’s bluebird bio BLUE Stock Holding History

Bank of America’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,274	Closed	-$714K	–	7428
2020 Q4	$714K	Buy	+1,274	New	+$807K	﹤0.01%	4762
2020 Q2	–	Sell	-2,146	Closed	-$1.28M	–	6830
2020 Q1	$1.28M	Buy	+2,146	New	+$2.09M	﹤0.01%	3852
2019 Q1	–	Sell	-1,065	Closed	-$1.37M	–	7106
2018 Q4	$1.37M	Buy	+1,065	New	+$1.63M	﹤0.01%	4159
2017 Q1	–	Sell	-903	Closed	-$722K	–	6971
2016 Q4	$722K	Buy	+903	New	+$717K	﹤0.01%	4565
2015 Q3	–	Sell	-6,871	Closed	-$15M	–	7207
2015 Q2	$15M	Buy	+6,871	New	+$14M	﹤0.01%	1629

Other funds holding BLUE

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's BLUE Position: Q2 2025 in Review

Bank of America sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 26,224 shares — an estimated $128K sold.

Bank of America first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $123M in Q1 2019. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

Bank of America reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
Bank of America sold 26,224 bluebird bio shares in Q2 2025, an estimated $128K.
Bank of America first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
Bank of America's bluebird bio position peaked at $123M in Q1 2019.
3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.